Wei Qiang Song
Director/Board Member at VANFUND URBAN INVESTMENT AND DEVELOPMENT CO., LTD.
Network origin in Wei Qiang Song first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Packaged Software | 20 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Wei Qiang Song via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| DANHUA CHEMICAL TECHNOLOGY CO.,LTD | Chemicals: Specialty | Director/Board Member | |
| PENGQI TECHNOLOGY DEVELOPMENT CO., LTD. | Industrial Machinery | Chairman Director of Finance/CFO | |
| Tsinghua University | College/University | Undergraduate Degree | |
| Southwest University | College/University | Undergraduate Degree | |
Wisefund Investment Holding Group Co., Ltd.
 Wisefund Investment Holding Group Co., Ltd. Real Estate DevelopmentFinance Wisefund Investment Holding Group Co., Ltd. is an investment holding company based in China. The Chinese company has interests in real estate development and mining, among other industries. Bin Hang has been the CEO of the company since 2004. | Real Estate Development | President | |
| TIBET AIM PHARM. INC. | Pharmaceuticals: Other | Director/Board Member | |
Harbin Zhudinggongda New Materials Technology Co., Ltd.
 Harbin Zhudinggongda New Materials Technology Co., Ltd. Other Metals/MineralsNon-Energy Minerals Harbin Zhudinggongda New Materials Technology Co., Ltd. is a company that manufactures non-ferrous metal alloy materials. The company is based in Harbin, China. The Chinese company was founded in 2015. The CEO is Da Wei Xing. | Other Metals/Minerals | Director/Board Member | |
Jilin Wanfang Baiao Biotechnology Co., Ltd.
 Jilin Wanfang Baiao Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Vanfund Urban Investment & Development Co., Ltd., Jilin Wanfang Baiao Biotechnology Co., Ltd. manufactures and sells pharmaceutical products. The company is based in Changchun, China. The Chinese company was founded in 2020. The CEO is Feng Chun Qi. Jilin Wanfang Baiao Biotechnology Co. was acquired by Vanfund Urban Investment & Development Co., Ltd. on January 26, 2022 for $3.29 million. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
| MEDLIVE TECHNOLOGY CO., LTD. | Miscellaneous Commercial Services | Founder | |
| Jinye Tiancheng Beijing Technology Co. Ltd. | President | ||
| Beijing Tekeneng Software Technology Co. Ltd. | Chief Executive Officer |
Statistics
International
| China | 11 |
| United States | 2 |
Sectoral
| Consumer Services | 3 |
| Health Technology | 3 |
| Process Industries | 2 |
| Producer Manufacturing | 2 |
| Finance | 2 |
Operational
| Director/Board Member | 23 |
| Independent Dir/Board Member | 7 |
| Chairman | 4 |
| Corporate Secretary | 4 |
| President | 3 |
Most connected contacts
| Insiders | |
|---|---|
| Li Xin Tian | 5 |
| Xing Gang Xiao | 3 |
| Yu Liu | 3 |
| Xu Ning Zhang | 2 |
| Han Hui Zhang | 2 |
| Zhi Wang Chen | 2 |
| Zi Bin Guo | 2 |
| Hui Zhang | 2 |
| Xiao Qing Li | 2 |
| Ke Wei Fang | 1 |
| Jian Qing Su | 1 |
| Chao Zhang | 1 |
| Ge Lin Liu | 1 |
| Chun Jing Wei | 1 |
| Na Ni | 1 |
- Stock Market
- Insiders
- Wei Qiang Song
- Company connections
